The Department of Homeland Security has issued an update to industry partners clarifying the current status of its Small Business Innovation Research (SBIR) and Small Business Technology Transfer ...

Local biotechs are sounding the alarm about the loss of federal funding for early-stage startups, and its impact on ...

The grant will fund preclinical studies of the dCK inhibitor TRE-515 with KRAS inhibitors in mice, which will then inform the design of clinical trials.

Trethera Corporation ('Trethera”), a clinical stage biopharmaceutical company developing first-in-class therapies for cancer ...

RespireRx Pharmaceuticals Inc. (“RespireRx” or the “Company”), a leader in the discovery and development of innovative and revolutionary treatments to combat diseases caused by disruption of neuronal ...

BrainCheck, the leading FDA Class II digital cognitive assessment and care platform, has been awarded a $500,000 SBIR Phase I grant (R43AG094410) from the National Institutes of Health (NIH) to ...

State-of-the-art technology could accelerate novel drug development, advance precision medicine Intellicule founders Purdue ...

Intellicule has received a $217,941 NIH SBIR Phase I grant to develop advanced deep-learning software for biomolecular modelling ...

Intellicule, a software company whose solutions determine the 3D structures of biomolecules imaged with cryogenic-electron microscopy (cryo-EM), has received a $217,941 Small Business Innovation ...

The National Institutes of Health longstanding "payline" has helped everyone see the connection between the scientific peer review process and NIH grant funding decisions. What will the latest NIH ...

What is the effectiveness of the Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) programs at the National Institutes of Health (NIH)? An ad hoc committee will ...